Medications starting with
Ukraine-
The drug is used for cough caused by acute or chronic respiratory diseases, such as bronchitis, laryngitis, tracheitis, bronchial asthma, and pertussis.
Dosage form: syrup
Active substance Dosage althaea root dry extract 7.5 mg ATC code: R05CA05
Manufacturer: PJSC "Halychpharm"
-
The drug is used for the complex treatment of acute and chronic inflammatory diseases of the respiratory tract, such as laryngitis, tracheitis, bronchitis, bronchial asthma, and whooping cough.
Dosage form: syrup
Active substance Dosage dry extract of marshmallow root 7.5 mg/5 ml ATC code: R05CA05
Manufacturer: Ternofarm LLC
-
The drug is used for the complex treatment of acute and chronic respiratory diseases accompanied by a cough with difficult phlegm expectoration (e.g., bronchitis, tracheitis, laryngitis, bronchial asthma, or pertussis).
Dosage form: syrup
Active substance Dosage althaea root extract 25 mg/5 ml ATC code: R05CA05
Manufacturer: LLC "Corporation "Zdorovya" (all manufacturing stages, quality control, batch release)
-
The drug is used to relieve dry cough and soothe irritation of the oral and pharyngeal mucosa. It is suitable for the complex treatment of acute and chronic respiratory diseases, such as laryngitis, tracheitis, bronchitis, bronchial asthma, and pertussis, when it is difficult to expectorate phlegm.
Dosage form: syrup
Active substance Dosage extract of dried roots of althea 25 mg/5 ml thyme herb dry extract 40 mg/5 ml ATC code: R05CA10
Manufacturer: LLC "Corporation "Zdorovya"
-
The drug is used for the symptomatic treatment of chronic idiopathic urticaria.
Dosage form: tablets, film-coated
Active substance Dosage fexofenadine 180 mg ATC code: R06AX26
Manufacturer: San Pharmaceutical Industries Limited
-
The preparation is used for respiratory tract diseases, such as chronic bronchitis, tracheitis, laryngitis, pneumonia, bronchial asthma, and whooping cough.
Dosage form: roots
Active substance Dosage althaea root 0 ATC code: R05CA05
Manufacturer: PJSC "Lektravy"
-
It is used for the complex treatment of acute and chronic respiratory tract inflammations, such as laryngitis, tracheitis, bronchitis, bronchial asthma, and whooping cough.
Dosage form: syrup
Active substance Dosage dry extract of marshmallow root 0.15 g/100 ml ATC code: R05CA05
Manufacturer: PJSC Pharmaceutical Factory "Viola"
-
The drug is used as adjunctive therapy for painful muscle spasms (contractures) arising from acute spinal diseases in adults and children aged 16 years and older.
Dosage form: solution for injection
Active substance Dosage thiocolchicoside 2 mg/ml ATC code: M03BX05
Manufacturer: LLC Firm Novofarm-Biosyntez
-
The drug is used in the complex therapy of heart and vascular diseases (stable angina, heart failure, cardiomyopathy), for cerebral circulation disorders (ischemic stroke), as well as for recovery after head injuries, encephalitis, or in cases of reduced work capacity and psycho-emotional strain.
Dosage form: solution for injection
Active substance Dosage 3-(2,2,2-trimethylhydrazine) propionate dihydrate 100 mg/ml ATC code: C01EB22
Manufacturer: PJSC "Lekhim-Kharkiv"
-
The drug is indicated for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) that is ALK-positive. It is used in both treatment-naïve patients and those whose disease has progressed following crizotinib treatment.
Dosage form: tablets, film-coated
Active substance Dosage brigatinib 30 mg ATC code: L01ED04
Manufacturer: Takeda Austria GmbH (batch release authorization)
-
The drug is intended for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) that is ALK-positive. It is used for both those who have not previously received treatment with ALK inhibitors and for patients whose disease has progressed after the use of crizotinib.
Dosage form: tablets, film-coated
Active substance Dosage brigatinib 90 mg ATC code: L01ED04
Manufacturer: Takeda Austria GmbH (batch release authorization)
-
The drug is indicated for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) that is ALK-positive. It is used in both treatment-naïve patients and those whose disease has progressed following crizotinib treatment.
Dosage form: tablets, film-coated
Active substance Dosage brigatinib 180 mg ATC code: L01ED04
Manufacturer: Takeda Austria GmbH (batch release authorization)
-
The drug is used for the treatment of patients with HIV infection in combination with other antiretroviral agents.
Dosage form: tablets, film-coated
Active substance Dosage lopinavir 100 mg ritonavir 25 mg ATC code: J05AR10
Manufacturer: AbbVie Deutschland GmbH & Co. KG (full production cycle)
-
The drug is used for the treatment of patients with HIV infection in combination with other antiretroviral agents.
Dosage form: tablets, film-coated
Active substance Dosage lopinavir 200 mg ritonavir 50 mg ATC code: J05AR10
Manufacturer: AbbVie Deutschland GmbH & Co. KG (full production cycle)
-
The drug is used for the treatment of major depressive episodes (and their prevention), generalized anxiety disorder, social phobia, and panic attacks.
Dosage form: capsules, extended-release
Active substance Dosage venlafaxine 37.5 mg ATC code: N06AX16
Manufacturer: KRKA, d.d., Novo mesto
-
The drug is used for the treatment of major depressive episodes (and their prevention), generalized anxiety disorder, social phobia, as well as panic attacks.
Dosage form: capsules, extended-release
Active substance Dosage venlafaxine 75 mg ATC code: N06AX16
Manufacturer: KRKA, d.d., Novo mesto
-
The drug is used for the treatment (and prevention) of major depressive episodes, generalized anxiety disorder, social phobia, as well as panic attacks.
Dosage form: capsules, extended-release
Active substance Dosage venlafaxine 150 mg ATC code: N06AX16
Manufacturer: KRKA, d.d., Novo mesto
-
The drug is used to treat bacterial infections such as meningitis, pneumonia (community-acquired and hospital-acquired), otitis, urinary tract infections, bone and joint infections, skin infections, as well as gonorrhea, syphilis, and endocarditis. It is also used for the prevention of infections before surgery and in the case of Lyme borreliosis.
Dosage form: powder for injection solution
Active substance Dosage ceftriaxone 1 g ATC code: J01DD04
-
The drug is used to treat bacterial meningitis, pneumonia (community-acquired and hospital-acquired), acute otitis media, intra-abdominal infections, complicated urinary tract infections, skin, soft tissue, bone, and joint infections, as well as gonorrhea, syphilis, and bacterial endocarditis. It is also used for the prevention of infections before surgery and in Lyme borreliosis.
Dosage form: powder for injection solution
Active substance Dosage ceftriaxone 1 g ATC code: J01DD04
Manufacturer: Laboratorios Reig Jofre, S.A.
-
The drug is used for the symptomatic treatment of Alzheimer's disease with mild to moderate severity.
Dosage form: tablets, dispersible in the oral cavity
Active substance Dosage donepezil 5 mg ATC code: N06DA02
Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.
-
The drug is used for the symptomatic treatment of Alzheimer's disease with mild to moderate severity.
Dosage form: tablets, dispersible in the oral cavity
Active substance Dosage donepezil 10 mg ATC code: N06DA02
Manufacturer: NOBEL ILAC SANAYI VE TICARET A.S.
-
The drug is used for the symptomatic treatment of Alzheimer's disease with mild to moderate severity.
Dosage form: tablets, film-coated
Active substance Dosage donepezil 10 mg ATC code: N06DA02
Manufacturer: PJSC Pharmaceutical Plant EGIS
-
The drug is used for the symptomatic treatment of Alzheimer's disease with mild to moderate severity.
Dosage form: tablets, film-coated
Active substance Dosage donepezil 5 mg ATC code: N06DA02
Manufacturer: PJSC Pharmaceutical Plant EGIS
-
The drug is used for the symptomatic treatment of allergic rhinitis (including perennial) and urticaria.
Dosage form: tablets, film-coated
Active substance Dosage levocetirizine 4.21 mg ATC code: R06AE09
Manufacturer: PJSC Pharmaceutical Plant EGIS
-
The drug is used for the symptomatic treatment of allergic rhinitis (including perennial) and urticaria.
Dosage form: drops, oral solution
Active substance Dosage levocetirizine 5 mg/ml ATC code: R06AE09
Manufacturer: PJSC Pharmaceutical Plant EGIS
-
The drug is used for postoperative pain relief (as part of multimodal analgesia), as well as for the treatment of acute pain conditions, such as injuries, pain following surgical interventions, or renal and hepatic colic.
Dosage form: solution for injection
Active substance Dosage nefopam 10 mg/ml ATC code: N02BG06
Manufacturer: PJSC "Lekhim-Kharkiv"
-
The drug is used to treat cognitive impairments in elderly people accompanied by memory problems, disorientation, confusion, decreased concentration, as well as changes in emotional state (irritability, apathy, emotional instability).
Dosage form: solution, oral
Active substance Dosage choline alfoscerate 600 mg/7 ml ATC code: N07AX02
Manufacturer: PJSC "Tekhnolog"
-
The drug is used for the treatment of arterial hypertension (high blood pressure) and ischemic heart disease.
Dosage form: tablets
Active substance Dosage perindopril 8 mg amlodipine 10 mg ATC code: C09BB04
-
The drug is used for the treatment of arterial hypertension (high blood pressure) and ischemic heart disease.
Dosage form: tablets
Active substance Dosage perindopril 3.338 mg amlodipine 5 mg ATC code: C09BB04
-
The drug is used for the treatment of arterial hypertension (high blood pressure) and ischemic heart disease.
Dosage form: tablets
Active substance Dosage perindopril 3.338 mg amlodipine 10 mg ATC code: C09BB04
-
The drug is prescribed for the treatment of arterial hypertension (high blood pressure) and ischemic heart disease.
Dosage form: tablets
Active substance Dosage perindopril 6.676 mg amlodipine 5 mg ATC code: C09BB04
-
The drug is used to treat symptoms of Parkinson's disease (tremor, muscle stiffness, movement disorders), as well as to eliminate side effects from other medications that cause motor activity disturbances.
Dosage form: tablets, film-coated
Active substance Dosage amantadine 100 mg ATC code: N04BB01
Manufacturer: Farmas Start LLC
-
The drug is used for the treatment and prevention of recurrences of ventricular arrhythmias, as well as for the prevention of supraventricular tachycardia. It may also be used to prevent electric shock injury in patients with implanted defibrillators.
Dosage form: capsules, prolonged-release
Active substance Dosage flecainide 50 mg ATC code: C01BC04
Manufacturer: Laboratorios Leti, S.A. (manufacturing "in bulk", primary and secondary packaging, quality control, batch control)
-
The drug is used for the treatment and prevention of certain types of heart rhythm disorders (ventricular and supraventricular arrhythmias), as well as for the prevention of electric shock in patients with implanted defibrillators.
Dosage form: capsules, prolonged-release
Active substance Dosage flecainide 100 mg ATC code: C01BC04
Manufacturer: Laboratorios Leti, S.A. (manufacturing "in bulk", primary and secondary packaging, quality control, batch control)
-
The drug is indicated for the treatment of type 2 diabetes in adults if blood sugar levels cannot be maintained by diet, physical exercise, and weight loss alone.
Dosage form: tablets
Active substance Dosage glimepiride 3 mg ATC code: A10BB12
Manufacturer: Sanofi S.R.L.
-
The drug is indicated for the treatment of type 2 diabetes in adults when blood sugar levels cannot be maintained by diet, physical exercise, and weight reduction alone.
Dosage form: tablets
Active substance Dosage glimepiride 2 mg ATC code: A10BB12
Manufacturer: Sanofi S.R.L.
-
The drug is prescribed for the treatment of type 2 diabetes mellitus in adults if blood sugar levels cannot be maintained by diet, physical exercise, and weight loss alone.
Dosage form: tablets
Active substance Dosage glimepiride 4 mg ATC code: A10BB12
Manufacturer: Sanofi S.R.L.
-
The drug is used for the rapid relief of moderate to severe acute postoperative pain. Treatment must be conducted only in an inpatient setting.
Dosage form: solution for injection
Active substance Dosage ketorolac 30 mg/ml ATC code: M01AB15
Manufacturer: Farmak JSC
-
The drug is used for the short-term treatment of moderate intensity pain, particularly postoperative pain.
Dosage form: tablets, film-coated
Active substance Dosage ketorolac 10 mg ATC code: M01AB15
Manufacturer: Farmak JSC
-
The drug is intended for the treatment of pulmonary arterial hypertension in adult patients (including idiopathic hypertension or connective tissue diseases).
Dosage form: tablets, film-coated
Active substance Dosage ambrisentan 5 mg ATC code: C02KX02
Manufacturer: APL Swift Services (Malta) Limited (Responsible for batch release)
-
The drug is intended for the treatment of pulmonary arterial hypertension in adult patients (WHO functional class II–III), specifically as part of combination therapy.
Dosage form: tablets, film-coated
Active substance Dosage ambrisentan 10 mg ATC code: C02KX02
Manufacturer: APL Swift Services (Malta) Limited (Responsible for batch release)
-
The drug is indicated to enhance pulmonary surfactant production in preterm infants and newborns with respiratory distress syndrome.
Dosage form: solution for injection
Active substance Dosage ambroxol 7.5 mg/ml ATC code: R05CB06
Manufacturer: Farmasel LLC
-
The drug is used to treat acute and chronic respiratory diseases accompanied by impaired mucus secretion and difficulty in its excretion.
Dosage form: syrup
Active substance Dosage ambroxol 15 mg/5 ml ATC code: R05CB06
Manufacturer: JSC "Sofarma" (manufacturing of unpackaged products, primary and secondary packaging; batch release authorization)
-
The drug is used to treat acute and chronic respiratory diseases accompanied by impaired secretion and difficult expectoration of phlegm.
Dosage form: capsules, extended-release
Active substance Dosage ambroxol hydrochloride 75 mg ATC code: R05CB06
Manufacturer: PJSC "Scientific and Production Center "Borshchahivskyy Chemical and Pharmaceutical Plant"
-
The drug is used for the treatment of acute and chronic respiratory diseases accompanied by impaired secretion and difficult mucus clearance.
Dosage form: tablets
Active substance Dosage ambroxol 30 mg ATC code: R05CB06
Manufacturer: LLC "Research Plant "GNCLS" (all manufacturing stages, quality control, batch release)
-
The drug is used to treat acute and chronic respiratory diseases accompanied by impaired mucus secretion and difficulty in its excretion.
Dosage form: tablets
Active substance Dosage ambroxol 30 mg ATC code: R05CB06
Manufacturer: Ternofarm LLC
-
The drug is used for the treatment of acute and chronic diseases of the bronchi and lungs accompanied by impaired secretion and difficulty in mucus expectoration.
Dosage form: syrup
Active substance Dosage ambroxol 15 mg/5 ml ATC code: R05CB06
Manufacturer: Ternofarm LLC
-
The drug is used for the treatment of acute and chronic diseases of the bronchi and lungs accompanied by impaired mucus secretion and difficulties in its excretion.
Dosage form: syrup
Active substance Dosage ambroxol 15 mg/5 ml ATC code: R05CB06
Manufacturer: PJSC "HIMFARMZAVOD "CHERVONA ZIRKA"
-
The drug is used for the treatment of acute and chronic respiratory diseases accompanied by impaired mucus secretion and difficulty in its excretion.
Dosage form: tablets
Active substance Dosage ambroxol 30 mg ATC code: R05CB06
Manufacturer: PJSC "Kyivmedpreparat"
-
The drug is used to treat acute and chronic diseases of the bronchi and lungs accompanied by impaired secretion and excretion of mucus.
Dosage form: syrup
Active substance Dosage ambroxol 15 mg/5 ml ATC code: R05CB06
Manufacturer: DKP "Pharmaceutical Factory" LLC